ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Mometason Spirig HC Nasenspray, Suspension - 140
67641001 Spirig HealthCare AG
Mometason Spirig HC Nasenspray, Suspension14.05.2020
Generic14.05.2020
Mometasone (R01AD09) 
WHO-DDD 
12.02.30.140
12.02.30. 
B  
Yes 
IPCI
6.25No
    
10 %16.05
  
7680676410018Synthetika
  
Composition
mometasoni furoas 0.5 mg ut mometasoni furoas monohydricus, benzalkonii chloridum 0.2 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum et carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata ad suspensionem pro 1 g corresp. mometasoni furoas 50 µg pro dosi, doses pro vase 140.
Packungsbestandteile
Suspension 
  
 
Active AgentDose
Mometasoni Furoas0.5 mg/g
BAG: Active AgentDose
Mometasone 17 Furoate0.05 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Benzalkonium Chloride0.2 mg/g
Carmellosum Natricum 
Cellulosum Microcristallinum 
Glycerol 
Natrii Citras Anhydricus 
Polysorbatum 80 
 
Source
Data was imported : 04.02.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home